HM Payson & Co’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $143K | Hold |
370
| – | – | ﹤0.01% | 512 |
|
|
2026
Q1 | $108K | Sell |
370
-67
| -15% | -$22K | ﹤0.01% | 537 |
|
|
2025
Q4 | $153K | Buy |
437
+57
| +15% | +$19.3K | ﹤0.01% | 480 |
|
|
2025
Q3 | $123K | Sell |
380
-146
| -28% | -$45.4K | ﹤0.01% | 525 |
|
|
2025
Q2 | $205K | Sell |
526
-100
| -16% | -$40.2K | ﹤0.01% | 415 |
|
|
2025
Q1 | $272K | Sell |
626
-80
| -11% | -$32.1K | ﹤0.01% | 366 |
|
|
2024
Q4 | $260K | Sell |
706
-24
| -3% | -$10K | ﹤0.01% | 368 |
|
|
2024
Q3 | $380K | Buy |
730
+101
| +16% | +$54K | 0.01% | 323 |
|
|
2024
Q2 | $341K | Buy |
629
+4
| +0.6% | +$2.11K | 0.01% | 324 |
|
|
2024
Q1 | $324K | Buy |
625
+17
| +3% | +$8.46K | 0.01% | 333 |
|
|
2023
Q4 | $287K | Sell |
608
-208
| -25% | -$96.2K | 0.01% | 336 |
|
|
2023
Q3 | $355K | Hold |
816
| – | – | 0.01% | 301 |
|
|
2023
Q2 | $363K | Sell |
816
-63
| -7% | -$29.1K | 0.01% | 299 |
|
|
2023
Q1 | $404K | Buy |
879
+25
| +3% | +$11.9K | 0.01% | 276 |
|
|
2022
Q4 | $438K | Buy |
854
+165
| +24% | +$83.8K | 0.01% | 262 |
|
|
2022
Q3 | $313K | Hold |
689
| – | – | 0.01% | 299 |
|
|
2022
Q2 | $332K | Sell |
689
-264
| -28% | -$131K | 0.01% | 302 |
|
|
2022
Q1 | $468K | Hold |
953
| – | – | 0.01% | 275 |
|
|
2021
Q4 | $442K | Hold |
953
| – | – | 0.01% | 294 |
|
|
2021
Q3 | $355K | Buy |
953
+14
| +1% | +$5.32K | 0.01% | 304 |
|
|
2021
Q2 | $359K | Hold |
939
| – | – | 0.01% | 305 |
|
|
2021
Q1 | $337K | Sell |
939
-48
| -5% | -$15.4K | 0.01% | 314 |
|
|
2020
Q4 | $317K | Buy |
987
+161
| +19% | +$49.4K | 0.01% | 325 |
|
|
2020
Q3 | $222K | Sell |
826
-166
| -17% | -$44.7K | 0.01% | 342 |
|
|
2020
Q2 | $261K | Sell |
992
-1,000
| -50% | -$267K | 0.01% | 306 |
|
|
2020
Q1 | $452K | Hold |
1,992
| – | – | 0.02% | 223 |
|
|
2019
Q4 | $602K | Hold |
1,992
| – | – | 0.02% | 246 |
|
|
2019
Q3 | $478K | Hold |
1,992
| – | – | 0.02% | 263 |
|
|
2019
Q2 | $562K | Buy |
+1,992
| New | +$544K | 0.02% | 257 |
|
|
2018
Q4 | – | Sell |
-1,492
| Closed | -$409K | – | 205 |
|
|
2018
Q3 | $409K | Hold |
1,492
| – | – | 0.02% | 244 |
|
|
2018
Q2 | $355K | Buy |
1,492
+39
| +3% | +$9.03K | 0.02% | 252 |
|
|
2018
Q1 | $319K | Buy |
1,453
+9
| +0.6% | +$2.11K | 0.01% | 264 |
|
|
2017
Q4 | $325K | Hold |
1,444
| – | – | 0.01% | 277 |
|
|
2017
Q3 | $274K | Hold |
1,444
| – | – | 0.01% | 280 |
|
|
2017
Q2 | $272K | Hold |
1,444
| – | – | 0.01% | 284 |
|
|
2017
Q1 | $239K | Hold |
1,444
| – | – | 0.01% | 301 |
|
|
2016
Q4 | $208K | Buy |
+1,444
| New | +$193K | 0.01% | 313 |
|
Other funds holding ELV
HM Payson & Co's ELV Position: Q2 2026 in Review
HM Payson & Co held its Elevance Health (ELV) position steady in Q2 2026 at 370 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #512.
HM Payson & Co first reported a position in ELV in Q4 2016 and has held it in 37 quarters since. The position peaked at $602K in Q4 2019. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- HM Payson & Co held 370 shares of Elevance Health worth $143K as of Q2 2026.
- HM Payson & Co left its Elevance Health share count unchanged in Q2 2026.
- Elevance Health made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #512 holding.
- HM Payson & Co first reported a position in Elevance Health in Q4 2016 and has held it in 37 quarters since.
- HM Payson & Co's Elevance Health position peaked at $602K in Q4 2019.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.